You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 12, 2025

Drug Price Trends for FOSINOPRIL-HYDROCHLOROTHIAZIDE


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for FOSINOPRIL-HYDROCHLOROTHIAZIDE

Average Pharmacy Cost for FOSINOPRIL-HYDROCHLOROTHIAZIDE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug NameNDCPrice/Unit ($)UnitDate
FOSINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB 69097-0973-07 0.54321 EACH 2025-03-19
FOSINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB 65862-0309-01 0.54321 EACH 2025-03-19
FOSINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB 65862-0308-01 0.49966 EACH 2025-03-19
FOSINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB 69097-0972-07 0.49966 EACH 2025-03-19
FOSINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB 65862-0309-01 0.55986 EACH 2025-02-19
FOSINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB 65862-0308-01 0.46429 EACH 2025-02-19
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 6 of 6 entries

Market Analysis and Price Projections for Fosinopril-Hydrochlorothiazide

Introduction to Fosinopril-Hydrochlorothiazide

Fosinopril-hydrochlorothiazide is a combination medication that belongs to the class of ACE inhibitors with thiazides. It is commonly prescribed for the treatment of high blood pressure. This medication combines the effects of fosinopril, an angiotensin-converting enzyme (ACE) inhibitor, and hydrochlorothiazide, a thiazide diuretic, to help lower blood pressure more effectively than either drug alone.

Market Overview of Antihypertensive Drugs

The global market for antihypertensive drugs is significant and growing, driven by several key factors. The rise in the incidence of hypertension worldwide, increased awareness of the complications associated with hypertension, and the growing geriatric population are major drivers of this market. According to Allied Market Research, the global antihypertensive drugs market was valued at $22,557 million in 2018 and is expected to reach $28,797 million by 2026, growing at a CAGR of 3.1% from 2019 to 2026[3].

Pricing of Fosinopril-Hydrochlorothiazide

The cost of fosinopril-hydrochlorothiazide can vary depending on the dosage and the pharmacy. Here are some price points for this medication:

  • 10 mg-12.5 mg Oral Tablet: The cost for a supply of 100 tablets is around $135.34 to $140.73, with a per-unit price ranging from $1.35 to $1.41[1].
  • 20 mg-12.5 mg Oral Tablet: Similarly, the cost for a supply of 100 tablets is around $135.34 to $140.73, with a per-unit price ranging from $1.35 to $1.41[1].

These prices are for cash-paying customers and do not apply to those with insurance plans. The use of discount cards, such as the Drugs.com Discount Card, can significantly reduce the cost of this medication.

Discount Programs and Patient Assistance

For patients who find the medication costly, several discount programs and patient assistance options are available:

  • Discount Cards: The Drugs.com Discount Card can save up to 80% or more off the cost of prescription medicines and is valid at most U.S. pharmacies[1][2].
  • Coupons, Copay Cards, and Rebates: While there are no manufacturer promotions currently available for fosinopril-hydrochlorothiazide, patients can look for other forms of savings such as printable coupons, rebates, or copay cards[1][2].
  • Patient Assistance Programs: Although no specific patient assistance programs were found for fosinopril-hydrochlorothiazide, healthcare providers may have information on other programs available in the area[1][2].

Market Trends and Growth Drivers

Increase in Hypertension Prevalence

The global prevalence of hypertension is a significant driver of the antihypertensive drugs market. According to the World Health Organization (WHO), approximately 1.13 billion people worldwide suffer from hypertension, and this number is expected to increase to 29% by 2025, particularly in economically developing nations[5].

Geriatric Population and Sedentary Lifestyle

The growing geriatric population and the increasing prevalence of sedentary lifestyles also contribute to the market growth. These factors lead to higher rates of hypertension and other cardiovascular diseases, thereby increasing the demand for antihypertensive medications[3][5].

Research and Development

The ongoing research and development in the field of antihypertensive drugs offer lucrative opportunities for market growth. New product launches and the development of novel drugs are expected to drive the market forward[5].

Regional Market Analysis

North America

North America holds a significant share of the antihypertensive drugs market due to the easy availability of these medications and the high incidence of hypertension in the region. This trend is expected to continue in the near future[3].

Asia-Pacific

The Asia-Pacific region is projected to exhibit the highest growth rate during the forecast period, driven by increasing awareness about the use of antihypertensive drugs and the evolving life science industry in countries like India, China, and Malaysia. India, in particular, is expected to grow at a CAGR of 5.1%[3].

Challenges and Restraints

Patent Expirations and Generic Competition

The antihypertensive drugs market faces challenges such as patent expirations of blockbuster drugs and increasing generic competition. These factors are expected to hinder market growth, particularly in the forecast period up to 2031, where the market is anticipated to decline at a CAGR of 1.4% due to cost-containment pressures and generic competition[4].

Side Effects

Another restraint is the side effects associated with hydrochlorothiazide, which can hamper the growth of the market. Patients and healthcare providers must weigh the benefits against the potential side effects when prescribing this medication[5].

Key Takeaways

  • Market Size and Growth: The global antihypertensive drugs market is expected to reach $28,797 million by 2026, growing at a CAGR of 3.1% from 2019 to 2026.
  • Pricing: Fosinopril-hydrochlorothiazide costs around $135 for a supply of 100 tablets, depending on the dosage and pharmacy.
  • Discount Programs: Various discount cards and patient assistance programs can help reduce the cost of the medication.
  • Regional Growth: The Asia-Pacific region is expected to exhibit the highest growth rate due to increasing awareness and the evolving life science industry.
  • Challenges: Patent expirations, generic competition, and side effects are significant challenges facing the market.

FAQs

What is fosinopril-hydrochlorothiazide used for?

Fosinopril-hydrochlorothiazide is used for the treatment of high blood pressure.

How much does fosinopril-hydrochlorothiazide cost?

The cost for a supply of 100 tablets of fosinopril-hydrochlorothiazide can range from $135.34 to $140.73, depending on the dosage and pharmacy.

Are there any discount programs available for fosinopril-hydrochlorothiazide?

Yes, discount cards like the Drugs.com Discount Card can save up to 80% or more off the cost of the medication.

What are the main drivers of the antihypertensive drugs market?

The main drivers include the rise in incidence of hypertension, increasing awareness of complications associated with hypertension, and the growing geriatric population.

What are the challenges facing the antihypertensive drugs market?

Challenges include patent expirations of blockbuster drugs, increasing generic competition, and side effects associated with certain medications.

Sources

  1. Drugs.com: Fosinopril/hydrochlorothiazide Prices, Coupons, Copay Cards & Patient Assistance[1].
  2. Drugs.com: Fosinopril Prices, Coupons, Copay Cards & Patient Assistance[2].
  3. Allied Market Research: Anti-hypertensive Drugs Market Size & Share Report 2033[3].
  4. iHealthcareAnalyst: Global Antihypertensive Drugs Market $20.5 Billion by 2031[4].
  5. Allied Market Research: Hydrochlorothiazide Market Size | Industry Growth, (2021-2030)[5].

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.